Author: Virginia Poole Arcangelo
Edition: Third
Binding: Paperback
ISBN: 1451111975
Edition: Third
Binding: Paperback
ISBN: 1451111975
Pharmacotherapeutics for Advanced Practice
AEstablished in its first two editions as the standardAadvanced pharmacotherapeutics text for nurse practitioners, students, and physician assistants this completely revised and updated new edition offers guidelines on prescribing drugs for over 50 common diseases and disorders. Organized by disorder rather than drug classAthis new editionAincludes algorithms and case studies that illustrate critical thinking aspects of prescribing, such as drug selection, lifespan considerations, therapeutic drug monitoring, adverse reactions, unexpected outcomes, and when to change therapy. The third edition includes coverage of pharmacogenomicsAandAtravel medicine.A The section on Depressive Disorders discusses weaning patients from SSRIs and changin author andrew m peterson author virginia poole arcangelo format paperback language english publication year 01 07 2005 subject medicine subject 2 medicine textbooks study guides title pharmacotherapeutics for advanced practice a practical approach author arcangelo virginia poole ph d editor peterson andrew m editor publisher lippincott williams wilkins publication date aug 30 2005 pages 959 binding paperback edition 2 nd dimensions 8 00 wx 10 75 hx 1 00 d isbn 0781757843 subject medical nursin Read medical textbooks online like Pharmacotherapeutics for Advanced Practice here
Pharmacotherapeutics for Advanced Practice : A Practical Approach
Pharmacotherapeutics for Advanced Practice : A Practical Approach, ISBN-13: 9780781757843, ISBN-10: 0781757843
Pharmacotherapeutics for Advanced Practice Lipph 9781451111972 09781451111972
Pharmacotherapeutics For Advanced Practice
Pharmacotherapeutics for Advanced Practice
Pharmacotherapeutics for Advanced Practice Online
Organized by disorder rather than drug classAthis new editionAincludes algorithms and case studies that illustrate critical thinking aspects of prescribing, such as drug selection, lifespan considerations, therapeutic drug monitoring, adverse reactions, unexpected outcomes, and when to change therapy
A The section on Depressive Disorders discusses weaning patients from SSRIs and changin
